Mark Andrew White - 31 Oct 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Manager, Commercial Affairs
Signature
/s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
Issuer symbol
RCKT
Transactions as of
31 Oct 2024
Net transactions value
-$51,205
Form type
4
Filing time
04 Nov 2024, 16:06:07 UTC
Previous filing
09 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $51,205 -3,080 -4.3% $16.62 69,140 31 Oct 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Remarks:

General Manager, Commercial Affairs